Confronting cancer in the Caribbean, through community, information and more than a little ‘bad mind’ and humour.
…
continue reading
Podcasts360, powered by Consultant360, features short interviews with medical professionals about current research, news, and general information for health care providers in 35+ specialties.
…
continue reading
Your professional development is critical to the care of your patients. Stay on top of the latest treatments and information with ReachMD's CME activities. Our topics span cardiology, diabetes, oncology, women's health and more. And our CME library is continuously growing, every quarter.
…
continue reading
Welcome to CEConversations, a clinical podcast presented by Creative Educational Concepts designed to improve clinician performance and optimize patient outcomes.
…
continue reading
Your professional development is critical to the care of your patients. Stay on top of the latest treatments and information with ReachMD's CME activities. Our topics span cardiology, diabetes, oncology, cardiology, women's health and more. And our CME library is continuously growing, every quarter.
…
continue reading
Featuring the video recorded proceedings of events held in conjunction with important scientific symposia, live webcasts and closed meetings featuring the perspectives of renowned clinical investigators, these videos provide an overview of important advances in the management of a number of solid tumors and hematologic cancers.
…
continue reading
Featuring one-on-one discussions with leading clinical investigators, this series bridges the gap between research and patient care by providing practicing medical and gynecologic oncologists with access to the latest research developments and expert perspectives on up-to-date clinical management strategies for gynecologic cancers.
…
continue reading
How does one break on through to the other side? But really - how do we foster bravery? Each episode, find out how innovators and trailblazers from every walk of life broke through in their chosen or created fields. A podcast meant to inspire, invigorate, inform and uplift.
…
continue reading
Medical oncologist Dr Neil Love interviews clinical investigators on new research and practical application to general medical oncology practice.
…
continue reading
Featuring one-on-one interviews conducted by Dr Neil Love, this series bridges the gap between research and patient care by providing urologists and radiation oncologists ongoing access to the perspectives and opinions of national and international prostate cancer research leaders.
…
continue reading
Welcome to touchPODCAST where you can listen and learn from our expert faculty, hand-picked from the Touch Medical Media family of independent medical websites. Educating physicians on a fully global scale since 2005! We make positive changes to clinical practice, with the ultimate objective of improving patient and community health. Working alongside leading medical experts, societies and industry, our mission is to provide practical, expert opinions to support best practices for busy Healt ...
…
continue reading
The mission of Oncology Data Advisor is to provide the multidisciplinary team with expert insights into clinical best practices and research progress in cancer care.
…
continue reading
The EMJ Podcast is an educational podcast for healthcare professionals that covers the forefront of clinical practice, offering insights into the cutting edge of medicine. Through conversations with key opinion leaders, our host, physician and entrepreneur Jonathan Sackier, explores the latest trends and innovations, covering a number of clinical specialties, including oncology, dermatology, urology, cardiology, and many more.
…
continue reading
Featuring one-on-one interviews conducted by Dr Neil Love, this series bridges the gap between research and patient care by providing medical oncologists, hematologists and hematology-oncology fellows ongoing access to the perspectives and opinions of national and international breast cancer clinical investigators.
…
continue reading
This series bridges the gap between research and patient care by providing medical oncologists and hematologists with ongoing access to the perspectives and opinions of national and international clinical investigators with expertise in gastrointestinal cancers.
…
continue reading
Updates on new data and best practices in the care of patients with cancer across a wide variety of solid tumors and hematologic malignancies from Clinical Care Options. Gain practical clinical insights and strategies and earn CME/CE credit for selected episodes.
…
continue reading
PeerView (PVI) is a leading provider of high-quality, innovative continuing education (CME/CE/CPE and MOC) for clinicians and their interprofessional teams. Combining evidence-based medicine and instructional expertise, PeerView activities improve the knowledge, skills, and strategies that support clinical performance and patient outcomes. PeerView makes its educational programming and expert-led presentations and symposia available through its network of popular podcast channels to support ...
…
continue reading
PeerView (PVI) is a leading provider of high-quality, innovative continuing education (CME/CE/CPE and MOC) for clinicians and their interprofessional teams. Combining evidence-based medicine and instructional expertise, PeerView activities improve the knowledge, skills, and strategies that support clinical performance and patient outcomes. PeerView makes its educational programming and expert-led presentations and symposia available through its network of popular podcast channels to support ...
…
continue reading
…
continue reading
Oncology Information Group is a global resource for the latest updates in oncology advancements. Subscribe to our podcast to receive the latest updates as they become available.
…
continue reading
CancerCare's free Connect Education Workshops are a way for people to learn about cancer-related issues from the convenience of their home or office. Leading experts in oncology provide the most up-to-date information in these workshops to help you and your loved ones better understand and cope with your cancer diagnosis, treatment options, quality-of-life concerns, treatment side effects, pain management, doctor-patient communication and other important topics.
…
continue reading
Hosted by Singapore's OG Influencer, Wendy Cheng aka Xiaxue, the #Nofilter podcast is XX’s unfiltered commentary on interesting news happening around the world. Plug in your earphones for a dose of brutal honesty and refreshing tirades. Catch our weekly episodes for more juicy news and remember to hit follow! BONUS: Click here to ask Xiaxue for advice or to have her read your dedication! p/s: Don't forget to 'follow' for more exciting content
…
continue reading
![Artwork](/static/images/128pixel.png)
1
HER2-Targeted ADCs in Advanced NSCLC: A Case-Based Approach to Targeted Treatment for Metastatic Disease
Host: Justin Gainor, MD Guest: Jacob Sands, MD The treatment landscape of non-small cell lung cancer (NSCLC) has dramatically changed over the past 20 years. In recent years, the discovery of targetable molecular alterations and the development of targeted therapies have dramatically changed the treatment outlook for NSCLC. Human epidermal growth f…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Advancements and Applications of Antibody Drug Conjugates in HER2-Negative Breast Cancer
50:54
50:54
Play later
Play later
Lists
Like
Liked
50:54
Patients with triple-negative and HR-positive/HER2-negative breast cancer have limited treatment options after the development of endocrine resistance. This dearth of options is particularly acute for Black women and other marginalized patients and results in treatment disparities. Antibody-drug conjugates (ADCs) are novel agents which may improve …
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Expanding the reach of HER2 in solid tumours: A spotlight on tumour-agnostic approaches
16:01
16:01
Play later
Play later
Lists
Like
Liked
16:01
touchFOCUS for touchONCOLOGY Listen to Dr Dana Chase discuss the role of HER2 as a pan-tumour biomarker and the implications for treatment across various cancer types. The expert Dr Dana Chase - UCLA Health, Los Angeles, CA, USA This touchPODCAST is for HCPs only. This activity is funded by an independent medical education grant from AstraZeneca. T…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Fransi Weinstein on her multi-award-winning career in advertising, writing her book, ACCEPTANCE, and fighting Stage 4 Hormone-positive HER2-negative breast cancer … with everything she’s got!
1:15:29
1:15:29
Play later
Play later
Lists
Like
Liked
1:15:29
To learn more and support Fransi please visit: https://www.gofundme.com/f/I-need-your-help-paying-for-my-cancer-care As always, thanks so much for tuning into Breaking Brave! If you like the show, please subscribe, review, and/or send us your suggestions or questions via the platforms below! For more from Marilyn Barefoot or to get in touch with he…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Oncology Today with Dr Neil Love: Optimizing the Identification of HER2-Low Breast Cancer
23:48
23:48
Play later
Play later
Lists
Like
Liked
23:48
Dr Kimberly H Allison from Stanford Cancer Institute in Stanford, California, discusses the optimal identification, pathologic reporting and treatment of HER2-low breast cancer.By Neil Love, MD
…
continue reading
![Artwork](/static/images/128pixel.png)
1
HER2-Low Breast Cancer | Oncology Today with Dr Neil Love: Optimizing the Identification of HER2-Low Breast Cancer
23:34
23:34
Play later
Play later
Lists
Like
Liked
23:34
Featuring an interview with Dr Kimberly H Allison, including the following topics: Contemporary practices in pathology and reporting biomarkers of interest (0:00) HER2 testing across numerous solid tumor types (2:47) ER-low reporting category and pathologic interpretation (6:28) PD-1/PD-L1 testing methodology and challenges with bone biopsies (10:5…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Optimizing the Identification of HER2-Low Breast Cancer
23:48
23:48
Play later
Play later
Lists
Like
Liked
23:48
Dr Kimberly H Allison from the Stanford Cancer Institute in Stanford, California discusses the optimal identification, pathologic reporting and treatment of HER2-low breast cancer, moderated by Dr Neil Love. Produced by Research To Practice. CME information and select publications here.By Research To Practice
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Next-Generation Therapeutics for HR+/HER2- Breast Cancer: Spotlight on SERDs
34:45
34:45
Play later
Play later
Lists
Like
Liked
34:45
In this episode, Dr Virginia Kaklamani moderates a discussion with Dr Aditya Bardia and Dr Sarah Sammons answering audience questions on the latest data on the use of oral SERDs therapy, including how to incorporate this new class of therapy into treatment plans for patients with HR+/HER2- breast cancer. Presenters: Virginia Kaklamani, MD, DSc Prof…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Cytomegalovirus in Stem Cell and Kidney Transplant: Overcoming the Limitations of Conventional Antiviral Therapy
53:18
53:18
Play later
Play later
Lists
Like
Liked
53:18
Cytomegalovirus (CMV) remains a major concern in both solid organ transplantation (SOT) and hematopoietic stem cell transplant (HSCT), primarily due to challenges related to treatment selection and monitoring, management of drug-related adverse events, and resistant/refractory disease. To minimize the impact of CMV infection in patients with HSCTs …
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Oncology Today with Dr Neil Love: Integrating Antibody-Drug Conjugates into the Management of HR-Positive and Triple-Negative Metastatic Breast Cancer
54:17
54:17
Play later
Play later
Lists
Like
Liked
54:17
Dr Sara A Hurvitz from the Fred Hutchinson Cancer Center in Seattle, Washington, summarizes recent trials investigating the integration of antibody-drug conjugates for HR-positive and triple-negative metastatic breast cancer, moderated by Dr Neil Love. Produced by Research To Practice. CME information and select publications here.…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Angela Lamarca, MD, PhD, MSc - Prioritising Patient-Centric Care in Biliary Tract Cancer: Leveraging Immunotherapy Platforms to Overcome Challenges in the Advanced Setting
22:50
22:50
Play later
Play later
Lists
Like
Liked
22:50
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups. For the full presentation, downloadable Practice Aids, slides, and complete CME information, and to apply for credit, please visit us at PeerView.com/EUX865. CME credit will…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Angela Lamarca, MD, PhD, MSc - Prioritising Patient-Centric Care in Biliary Tract Cancer: Leveraging Immunotherapy Platforms to Overcome Challenges in the Advanced Setting
22:50
22:50
Play later
Play later
Lists
Like
Liked
22:50
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups. For the full presentation, downloadable Practice Aids, slides, and complete CME information, and to apply for credit, please visit us at PeerView.com/EUX865. CME credit will…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Selecting ART: Working with people living with HIV to find the best regimen
39:45
39:45
Play later
Play later
Lists
Like
Liked
39:45
touchIN CONVERSATION for touchINFECTIOUS DISEASES Listen to a conversation between Dr Christoph Boesecke and Dr Tristan Barber, two experts on HIV practising in Germany and the UK. They respond to questions submitted by the HCP audience and provide their insights on best practices for antiretroviral therapy selection for people living with HIV. The…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Lung Cancer | Oncology Today with Dr Neil Love: Novel Agents and Strategies in Lung Cancer
1:01:44
1:01:44
Play later
Play later
Lists
Like
Liked
1:01:44
Featuring perspectives from Dr Melissa Johnson, Dr Ticiana Leal and Dr Manish Patel, including the following topics: Introduction: Two Faces of Lung Cancer Research (0:00) B7-H3-Targeted Antibody-Drug Conjugates for Lung Cancer — Dr Patel (16:14) Potential Role of Tumor Treating Fields in the Management of Metastatic Non-Small Cell Lung Cancer — Dr…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Episode 215: Innovations in Vascular Medicine: From Bench to Bedside
40:10
40:10
Play later
Play later
Lists
Like
Liked
40:10
Shaping the field of cardiovascular medicine, emerging technologies have the potential to transform the treatment of vascular disease. Explore the latest advancements in cardiology with Jonathan and Nicholas Leeper, Professor of Surgery, Chief of Vascular Medicine, and Director of Vascular Research at Stanford University, California, USA. Timestamp…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Novel Agents and Strategies in Lung Cancer
1:01:43
1:01:43
Play later
Play later
Lists
Like
Liked
1:01:43
Dr Melissa Johnson from Sarah Cannon Research Institute in Nashville, Tennessee, Dr Ticiana Leal from Winship Cancer Institute of Emory University in Atlanta, Georgia, and Dr Manish Patel from Florida Cancer Specialists & Research Institute in Sarasota, Florida, summarize recently presented advancements, including novel strategies, in the treatment…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
HER2-Targeted ADCs in Advanced NSCLC: A Case-Based Approach to Targeted Treatment for Metastatic Disease
CME credits: 0.50 Valid until: 13-08-2025 Claim your CME credit at https://reachmd.com/programs/cme/her2-targeted-adcs-in-advanced-nsclc-a-case-based-approach-to-targeted-treatment-for-metastatic-disease/26285/ The treatment landscape of non-small cell lung cancer (NSCLC) has dramatically changed over the past 20 years. In recent years, the discove…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Personalizing care within the MDT for patients with early through to advanced RCC
19:36
19:36
Play later
Play later
Lists
Like
Liked
19:36
touchFOCUS for touchONCOLOGY Listen to Prof. Hans Hammers as he answers a series of questions on the application of prognostic markers and clinical data within the multidisciplinary team to personalize care for patients with early stage through to advanced and metastatic RCC. In addition, he responds to questions on the use of effective communicati…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Multiple Myeloma | Jesús G Berdeja, MD
1:00:33
1:00:33
Play later
Play later
Lists
Like
Liked
1:00:33
Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Multiple Myeloma | Faculty Presentation 2: Chimeric Antigen Receptor T-Cell Therapy, Bispecific Antibodies and Antibody-Drug Conjugates for MM — Jesús G Berdeja, MD CME information and select publications…
…
continue reading
Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Multiple Myeloma | Faculty Presentation 1: Current and Emerging Therapeutic Approaches for Multiple Myeloma (MM) — Thomas Martin, MD CME information and select publicationsBy Dr. Neil Love
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Multiple Myeloma | Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Multiple Myeloma
1:02:04
1:02:04
Play later
Play later
Lists
Like
Liked
1:02:04
Featuring perspectives from Dr Jesús G Berdeja and Dr Thomas Martin, including the following topics: Introduction: Real-World Regulatory Issues in Multiple Myeloma (MM) (0:00) Newly Diagnosed MM (14:30) Novel Agents for Relapsed/Refractory MM (24:58) Chimeric Antigen Receptor T-Cell Therapy and Bispecific Antibodies (44:28) CME information and sele…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Skin Cancer | Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Melanoma and Nonmelanoma Skin Cancers
59:36
59:36
Play later
Play later
Lists
Like
Liked
59:36
Featuring perspectives from Dr Evan J Lipson, including the following topics: Introduction: Johns Hopkins University (0:00) Metastatic Melanoma (8:21) Nonmetastatic Melanoma and Other Skin Cancers (34:20) CME information and select publicationsBy Dr. Neil Love
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Multiple Myeloma
1:02:03
1:02:03
Play later
Play later
Lists
Like
Liked
1:02:03
Dr Jesús G Berdeja from the Greco-Hainsworth Tennessee Oncology Centers for Research in Nashville and Dr Thomas Martin from UCSF Helen Diller Family Comprehensive Cancer Center in San Francisco discuss the most relevant new data sets and advances in multiple myeloma, moderated by Dr Neil Love. Produced by Research To Practice. CME information and s…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Case in Point: The Use of GnRH Antagonists Pre- and/or Post-Surgery and the Potential Consequences of Repeat Surgery
CME credits: 0.50 Valid until: 09-08-2025 Claim your CME credit at https://reachmd.com/programs/cme/case-in-point-the-use-of-gnrh-antagonists-pre-andor-post-surgery-and-the-potential-consequences-of-repeat-surgery/24400/ While both medical therapy and surgery often play a role in a woman’s journey with endometriosis, it is less clear how to best se…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Pain Points: Weighing the Benefits and Drawbacks of the GnRH Antagonists Throughout the Endometriosis Treatment Journey
Host: Lee P. Shulman, MD, FACMG, FACOG Guest: Ayman Al-Hendy, MD, PhD, FRCSC, FACOG, CCRP Guest: Sawsan As-Sanie, MD GnRH antagonists have emerged as a viable first-line (or subsequent-line) medical therapy for the management of endometriosis. They have proven to be effective and safe, and their use avoids the flare response observed with GnRH agon…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Pain Points: Weighing the Benefits and Drawbacks of the GnRH Antagonists Throughout the Endometriosis Treatment Journey
CME credits: 0.50 Valid until: 09-08-2025 Claim your CME credit at https://reachmd.com/programs/cme/pain-points-weighing-the-benefits-and-drawbacks-of-the-gnrh-antagonists-throughout-the-endometriosis-treatment-journey/24399/ GnRH antagonists have emerged as a viable first-line (or subsequent-line) medical therapy for the management of endometriosi…
…
continue reading
CME credits: 0.50 Valid until: 09-08-2025 Claim your CME credit at https://reachmd.com/programs/cme/creating-a-practice-environment-that-enhances-healthcare-equality-for-all-patients/24397/ Both provider- and patient-related healthcare disparities exist in the diagnosis and management of endometriosis. Many disparities derive from incorrect histori…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
The Impact of Early Diagnosis in Improving Patient Outcomes in Endometriosis: Physical and Psychosocial Consequences
CME credits: 0.25 Valid until: 09-08-2025 Claim your CME credit at https://reachmd.com/programs/cme/the-impact-of-early-diagnosis-in-improving-patient-outcomes-in-endometriosis-physical-and-psychosocial-consequences/24396/ Endometriosis is often called a public health crisis for women. The delay in diagnosis can be greater than 10 years, during whi…
…
continue reading
CME credits: 0.25 Valid until: 09-08-2025 Claim your CME credit at https://reachmd.com/programs/cme/patient-centric-tools-to-support-shared-decision-making-diagnosing-and-assessing-endometriosis/24398/ The use of validated patient questionnaires, notably the SF-36 and EHP-30 scales, can greatly hasten the suspicion for an endometriosis diagnosis. C…
…
continue reading